Evidence. Excellence. Education.
Longevity Industry Consulting
BILM provides specialist industry consulting for organisations working in longevity medicine, preventive medicine and regenerative health. We help companies, investors and innovators navigate a field that is growing quickly, but still requires careful clinical scrutiny, strong governance and clear evidence.
As a UK learned society and professional body for GMC‑registered doctors, BILM brings a clinically credible, standards-led perspective to industry projects, helping ensure that products, services and claims are developed responsibly and positioned appropriately.
What we do
We aim to help organisations align innovation with evidence, and commercial ambition with clinical integrity.
Our industry consulting service may include:
- Clinical and scientific review of new products or services.
- Advice on longevity medicine positioning and market readiness.
- Evidence appraisal for supplements, diagnostics, devices and digital health tools.
- Input on protocol development and clinical pathways.
- Support with risk, safety, contraindications and monitoring frameworks.
- Review of marketing language, claims and educational materials.
- Strategic advice for companies entering the longevity medicine market.
Sectors we support
BILM may work with a range of industry partners, including:
Supplement and nutraceutical companies.
Medical device and wearable technology firms.
Digital health and biomarker companies.
Longevity clinic groups and health optimisation providers.
Pharmaceutical and biotech organisations exploring ageing-related indications.
Investors and founders seeking clinical due diligence.
Media, education and content organisations covering longevity medicine.
Working with BILM can help you:
Strengthen scientific credibility.
Reduce avoidable clinical and reputational risk.
Improve product and service design.
Support ethical and evidence-based marketing.
Better understand what is realistic, permissible and defensible in UK practice.
Build greater trust with doctors, patients and stakeholders.
Why BILM Consulting?
The longevity sector is expanding rapidly, but it is not always easy to distinguish robust innovation from overstated claims. BILM offers a trusted, medically informed perspective that can help organisations make better decisions earlier.
Our approach
We are pragmatic, independent and evidence-led. We do not simply assess whether an idea is commercially attractive; we assess whether it is clinically plausible, ethically defensible and supported by the best available evidence.
Where relevant, our consulting may draw on:
Systematic literature review.
Clinical judgement and guideline-level thinking.
Risk-benefit analysis.
Real-world service design considerations.
Patient safety and governance principles.
Longevity clinic standards and professional expectations.
Examples of consulting work
Depending on your needs, BILM may be able to support:
A supplement brand seeking an independent medical review of product claims.
A clinic launching a new longevity programme and needing clinical pathway input.
A medtech company developing a biomarker platform for healthspan assessment.
A biotech or investor team assessing the viability of a new ageing-related concept.
An education company wanting medically accurate longevity content.
Enquiries
If your organisation is working in longevity medicine, preventive medicine or regenerative health, BILM can help you assess the clinical, scientific and strategic considerations with confidence.